BioCurex, Inc.(fka BOCX)

[opportunityknocking]

According to the website slide presentation, management gave themselves 18 months from 1/1/2010. We must see FDA trials NOW. YOU CANNOT SELL A TEST THAT HAS NOT BEEN FDA APPROVED!!!! There seems to be a lack of direction. Every press release sends a different message. They were supposed to license oncopet, and now without a full explanation he decided to self market and go it alone. IMO all the energy and dollars should have been focused on getting an FDA approval for recaf. Failure to do so is like going to medical school and not passing the board exams. You cannot practice without a license. You have a product that cannot be sold. What are you waiting for? I thought lessons were learned after the near collapse of the company, but we seem to be backpeddling again. Spend the money shareholders approved on what you said you were going to use the money for....FDA approval. Then shareholders will at least feel that recaf has a future, otherwise this was a big mistake for me. It is usually the other way around where a biotech company jumps the gun too early and fails trials. Dr Moro you know you have adequate data to present to the FDA, so I really am getting upset that you don't seem too concerned that the share price is at this level because you are not proceeding with trials. I have every right to express my concerns after being patient for 6 years. You also have no projections for oncopet. Why? I don't give a sheet in Goldseeker's response. I'd like to hear from you!